Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2016-01-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Negative Oral Contrast Agents Utilization in PET/CT Studies
NCT04577586
Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
NCT00478556
Improved Chest CT Diagnostic and Contrast Medium Administration
NCT05645796
Individualized Volume of Oral Contrast Agent in CT Enterography
NCT03808649
Uniformity of Oral Contrast Material in the Bowel
NCT02542046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavored contrast
This group of patients will have the choice to flavor their contrast.
No interventions assigned to this group
Unflavored contrast
This group of patients will drink the contrast without flavoring.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
8 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kelly Dietz, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1507M76622
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.